# The Effect of Sulfasalazine on CRH Levels in Pregnant Women

> **NCT05703425** · PHASE2 · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 50 (estimated)

## Conditions studied

- Preterm Birth

## Interventions

- **DRUG:** Sulfasalazine

## Key facts

- **NCT ID:** NCT05703425
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05703425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05703425, "The Effect of Sulfasalazine on CRH Levels in Pregnant Women". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05703425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*